echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Ann Neurol-New study finds genetic risk sites for cluster headaches

    Ann Neurol-New study finds genetic risk sites for cluster headaches

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cluster headache (CH) is a primary headache disease characterized by strong unilateral orbital, supraorbital, and/or temporal pain, lasting 15-180 minutes, and accompanied by symptoms of autonomic nerves on the same side and / Or irritability
    .


    Most patients have paroxysmal CH.


    Current treatment strategies include suspension of acute episodes, aims to prevent reduction in seizure frequency of treatment


    Blood vessel


    They found that four independent locus (loci) (r2<0.


    1) are associated with cluster headache and have genome-wide significance (p<5×10-8), rs11579212 (OR=1.
    51), rs6541998 (OR=1.
    53) , Rs10184573 (OR = 1.
    43) and rs2499799 (OR = 0.
    62, 95% CI 0.
    54-0.
    73, close to UFL1/FHL5), together explain 7.
    2% of the phenotypic variation



    The important significance of this research is that the genetic risk site of cluster headache was discovered and replicated through GWAS , and its effect size is larger than that usually seen in complex genetic diseases
    .

    Through GWAS , the genetic risk locus of cluster headache was discovered and replicated, and its effect size is larger than usually seen in complex genetic diseases
    .


    Through GWAS , the genetic risk locus of cluster headache was discovered and replicated, and its effect size is larger than that usually seen in complex genetic diseases


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.